Renalytix raises up to $4M in registered direct offering with DB Capital Partners

Renalytix plc

Initial tranche of $1.0M at $0.75 per ADS ($0.375 per ordinary share) closing by April 11.
Optional second tranche of up to ~$3M at same price, exercisable until April 17.
Net proceeds to support commercial sales activity and ongoing Formal Sale Process.
Purchaser DB Capital Partners Healthcare will hold ~2.18% of shares after initial closing.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.